a2 Collective Leadership

The a2 Collective represents the Artificial Intelligence and Technology Collaboratories (AITC) for Aging Research program funded by the National Institute on Aging (NIA), part of the National Institutes of Health. The a2 Collective comprises three AITCs centered at Johns Hopkins University (JH AITC), the University of Massachusetts Amherst (MassAITC), and the University of Pennsylvania (PennAITech) and the a2 Collective Coordinating Center managed by Rose Li and Associates, Inc. (RLA).

Rose Li, PhD, MBA

Co-Principal Investigator

Albert Lee, PhD

Co-Principal Investigator

Stephen C. Liu, MBA

Managing Director
Marketing/Business Development

Kayla Harr, PhD

Project Manager

Alice Wang, MHS

Project Coordinator
Central IRB

Colette Li, PhD

Program Analyst

Jackie Basu, PhD

AI Ethics Lead

Amanda Curran

Sponsorship Administrator

Chanley Mash

Conference Coordinator

Ella Blue

Conference Coordinator

Research Collaboratories

Learn more about each AITC’s team by visiting their website below:

Partha Bhattacharyya, PhD

AITC Program Officer
Program Director
Division of Behavioral and Social Research

Rebecca Krupenevich, PhD

AITC Program Officer
Program Official
Division of Behavioral and Social Research

Marcel Salive, MD, MPH

AITC Program Officer
Health Scientist Administrator
Division of Geriatrics and Clinical Gerontology

Abdulaziz Abubshait, PhD

AITC Project Scientist
AAAS Science & Technology Policy Fellow
Office of Data Resources and Analytics

Joe Chiarenzelli, MPH

AITC Project Scientist
Program Officer
Office of Data Resources and Analytics

Megan Hancock

Grants Management Specialist
Grants and Contracts Management Branch

External Advisory Panel

Current Members
‍
Cansu Canca, PhD (2022–Present)
Founding Director, AI Ethics Lab
Research Associate Professor and Director of Responsible AI Practice, Institute for Experiential AI, Northeastern University
I. Glenn Cohen, JD (2024–Present)
Deputy Dean and James A. Attwood and Leslie Williams Professor of Law, Harvard Law School
Faculty Director, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics
Winn Hong, MBA, MS (2022–Present)
Cofounder, President, and CEO, Mesencyte Inc.
North America Venture Manager, Nokia Ventures
Susann Keohane, MS (2022–Present)
Head of Emerging AI Product Innovation, IBM
Chaiwoo Lee, PhD (2022–Present)
Research Scientist, MIT AgeLab
Hon Pak, MD, MBA (2022–Present)
Senior Vice President and Head of Digital Health Team, Samsung Electronics
Michael Synder, PhD (2024–Present)
Stanford W. Ascherman Professor of Genetics, Stanford University
Director, Stanford Center for Genomics and Personalized Medicine
Alex Zhavoronkov, PhD (2022–Present)
Founding CEO, Insilico Medicine
Former Member
‍
Diane Ty, MA, MBA (2022–2024)
Managing Director, Milken Institute Future of Aging
Senior Advisor, Business for Impact, McDonough School of Business, Georgetown University

ACKNOWLEDGMENTS

We thank the following reviewers for sharing their industry perspective in evaluating selected pilot applications as part of the a2 Collective review processes undertaken in September 2024 and March 2025.

‍Ray Jang, MBA
Principal, Primetime Partners
Jun Jeon, MD
Principal, Khosla Ventures
Stephen Johnston, MBA
Fellow, Healthy Longevity, SOMPO Digital Lab
Founder, Looking Forward
Managing Director, Fordcastle
Kat Mackenzie, MBA, MPH 
Director of Strategy, The Future of Healthcare, Humana Military
Kuldeep Neote, PhD (September 2024 only)
Entrepreneur-in-Residence, Office of Strategic Extramural Programs, NIA
Strategic Advisor, KSN Consulting LLC
Richard Singerman, PhD
Principal, Rios Partners